Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by MyKnighton Apr 07, 2022 11:06am
119 Views
Post# 34584212

Claritas

ClaritasBeen here since the begining about 5 years now....I understand the frustration of the warrant holder.
I believe that Salzman is taking advantage of is position only for is own gain. I even think that they are naked shorting this stock to serve their own agenda.

This being said I don't have any warrant only share.
I still believe this has high potential and that we should see the price get higher after the warrant expiry date:(

I wish the best of luck for every owner.

RE:RE:Hey Bob Farrell, is it time for a RS again?

After all, this is SMOKE & MIRROR show and this F...ers will do what is takes to milk investors to death!!  EMPTY PROMISES.......No mention of PROMISES they made to B warrant holders when they fooled them into purchaing them.......These F....ers are criminals and fraudesters with smooth tongues. The SP is sitting at ONE-THIRD of what it was at RS time and only SALZMAN was smart enough to off load......After all they get FREE shares though dilution PEROIDICALLY....
<< Previous
Bullboard Posts
Next >>